Share

TIGIT-MM001

Evaluation of TIGIT expression in newly diagnosed Multiple Myeloma and correlation with the characteristics of the disease.

Project objectives

To evaluate the presence of the expression of positive TIGIT lymphocytes in the medullary blood of newly diagnosed Multiple Myeloma patients and correlation with the clinical characteristics of the disease.

Start and end date
 December 2022

Project Manager
Ombretta Annibali- Principal Investigator

Coordinating institution of the project
Campus Bio Medico Polyclinic Foundation of Rome

Other Institutions involved
  • Uos Uos-D Pathology of endocrine and neuromuscular organs, Fondazione Policlinico Universitario Campus Bio-Medico 

Funding source(s).
• Center of Excellence for Nursing Culture and Research, Rome

Economic value of the project

62.400 €
2023© Università Campus Bio-Medico di Roma, Via Álvaro del Portillo, 21 - 00128 Rome, Tel. +39 06.22541.1, Fax +39 06.22541.456, VAT number: 048 020 51 005, Fiscal Code: 97087620585
QUICK LINKS
L'Università Campus Bio-Medico di Roma promotes integrated teaching and research structures, pursuing the good of the person as the main aim of its activities.
magnifiercrossmenuchevron-downchevron-leftchevron-right